Michael Mulligan
Overview
Explore the profile of Michael Mulligan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlozzi L, Lee J, Barros L, Buber Y, Chen D, Mulligan M, et al.
Respir Med
. 2023 Mar;
211:107215.
PMID: 36934856
Introduction: Balloon pulmonary angioplasty (BPA) is a less invasive treatment alternative for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are unable to move forward with pulmonary thromboendarterectomy. This report...
2.
Khorsandi M, Keenan J, Adcox M, Tabesh A, Badulak J, Pal J, et al.
J Cardiothorac Surg
. 2022 Nov;
17(1):282.
PMID: 36335383
Background: Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) is an effective, but highly resource intensive salvage treatment option in COVID patients with acute respiratory distress syndrome (ARDS). Right ventricular (RV) dysfunction...
3.
Coston T, Vaidya S, Badulak J, Garcia D, Keel S, Mulligan M, et al.
Chest
. 2022 Jul;
162(1):e5-e8.
PMID: 35809951
Extracorporeal membrane oxygenation (ECMO) increasingly is being used to support acute respiratory failure and for bridging to lung transplantation. Bleeding and thrombosis are common complications in the acute setting, but...
4.
Mulligan M, Bonar F, Fanburg-Smith J, Melhem L, Messiou C, Kocoglu M, et al.
Cancer Invest
. 2022 Mar;
40(6):544-553.
PMID: 35275786
Multiple myeloma and its precursor and variant types represent some of the most common hematologic malignancies in adults. These plasma cell dyscrasias are well-known in modern medicine. There are well-established...
5.
Carraro G, Langerman J, Sabri S, Lorenzana Z, Purkayastha A, Zhang G, et al.
Nat Med
. 2021 May;
27(5):806-814.
PMID: 33958799
Cystic fibrosis (CF) is a lethal autosomal recessive disorder that afflicts more than 70,000 people. People with CF experience multi-organ dysfunction resulting from aberrant electrolyte transport across polarized epithelia due...
6.
Hady T, Hwang B, Pusic A, Waworuntu R, Mulligan M, Ratner B, et al.
J Tissue Eng Regen Med
. 2020 Nov;
15(1):24-36.
PMID: 33217150
Implanted porous precision templated scaffolds (PTS) with 40-µm spherical pores reduce inflammation and foreign body reaction (FBR) while increasing vascular density upon implantation. Larger or smaller pores, however, promote chronic...
7.
Ahmed S, Jubouri S, Mulligan M
Skeletal Radiol
. 2020 Nov;
50(6):1189-1196.
PMID: 33169221
Objective: To determine the rate of chondrosarcoma in incidentally discovered painless long bone cartilage lesions and to determine if any further imaging is needed. Materials And Methods: A cartilage lesion...
8.
Copeland H, Awori Hayanga J, Neyrinck A, Macdonald P, Dellgren G, Bertolotti A, et al.
J Heart Lung Transplant
. 2020 Jun;
39(6):501-517.
PMID: 32503726
Heart and lung procurements are multiphased processes often accompanied by an array of complex logistics. Approaches to donor evaluation and management, organ procurement, and organ preservation vary among individual procurement...
9.
Leiva-Juarez M, Urso A, Arango Tomas E, Lederer D, Sanchez P, Griffith B, et al.
J Heart Lung Transplant
. 2020 Jun;
39(9):954-961.
PMID: 32475748
Background: Ex vivo lung perfusion (EVLP) allows for a reassessment of lung grafts initially deemed unsuitable for transplantation, increasing the available donor pool; however, this requires a pre- and post-EVLP...
10.
Scallan C, Venado A, Han L, Xu H, Mulligan M, Raghu G
Ann Am Thorac Soc
. 2020 May;
17(7):901-904.
PMID: 32437253
No abstract available.